Segment Information - Segment Revenue, Operating (Loss) Income and Depreciation and Amortization (Detail) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Revenue	$ 23,003	$ 22,297
Operating (loss) income	(3,441)	93
Depreciation and amortization	2,376	1,860
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	23,003	22,297
Operating (loss) income	(637)	2,627
Operating Segments [Member] | Medical Device [Member]
Segment Reporting Information [Line Items]
Revenue	16,908	16,196
Operating (loss) income	(3,792)	(593)
Depreciation and amortization	2,194	1,652
Operating Segments [Member] | In Vitro Diagnostics [Member]
Segment Reporting Information [Line Items]
Revenue	6,095	6,101
Operating (loss) income	3,155	3,220
Depreciation and amortization	86	105
Corporate Non Segment [Member]
Segment Reporting Information [Line Items]
Operating (loss) income	(2,804)	(2,534)
Depreciation and amortization	$ 96	$ 103